Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

XBiotech Inc. Director's Dealing 2015

Apr 14, 2015

34229_dirs_2015-04-14_bb8fc8f3-6283-4053-9448-2421063761e5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2015-04-14

Reporting Person: MCKENZIE W THORPE (Director, 10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3375000 Direct
Common Stock 610996 Indirect
Common Stock 100000 Indirect
Common Stock 100000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $3.75 2019-11-29 Common Stock (185000) Direct
Stock Option $3.75 2020-01-24 Common Stock (77000) Direct
Stock Option $3.75 2020-01-31 Common Stock (46000) Direct
Stock Option $3.75 2020-03-28 Common Stock (327000) Direct
Stock Option $3.75 2020-07-13 Common Stock (320000) Direct
Stock Option $3.75 2020-12-14 Common Stock (45000) Direct
Stock Option $10.00 2021-12-30 Common Stock (250000) Direct
Stock Option $15.00 2023-12-31 Common Stock (90000) Direct
Stock Option $15.00 2024-12-31 Common Stock (15000) Direct